Business Description
Pila Pharma AB
ISIN : SE0015988274
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.7 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.58 | |||||
Debt-to-EBITDA | -0.17 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 13.24 | |||||
Beneish M-Score | -5.25 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 1.2 | |||||
3-Year EPS without NRI Growth Rate | -13.1 | |||||
3-Year FCF Growth Rate | -22.9 | |||||
3-Year Book Growth Rate | 9.5 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56 | |||||
9-Day RSI | 56.22 | |||||
14-Day RSI | 54.1 | |||||
6-1 Month Momentum % | 340.04 | |||||
12-1 Month Momentum % | 163.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.47 | |||||
Quick Ratio | 1.47 | |||||
Cash Ratio | 1.33 | |||||
Days Sales Outstanding | 12.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.9 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -436.98 | |||||
Net Margin % | -678.74 | |||||
FCF Margin % | -324.62 | |||||
ROE % | -316.09 | |||||
ROA % | -194.32 | |||||
ROIC % | -174.72 | |||||
3-Year ROIIC % | 128.2 | |||||
ROCE % | -314.79 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 71.94 | |||||
PB Ratio | 47.96 | |||||
EV-to-EBIT | -14.05 | |||||
EV-to-EBITDA | -15.77 | |||||
EV-to-Revenue | 94.96 | |||||
EV-to-FCF | -28.42 | |||||
Earnings Yield (Greenblatt) % | -7.13 | |||||
FCF Yield % | -3.42 |